← Back to Search

Other

CPAP Therapy for Sleep Apnea in Spinal Cord Injury

N/A
Recruiting
Led By Julio Furlan, MD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
English-speaking adults 18 years of age or older
Have traumatic cervical/thoracic (injury level at C5 to T10), severe or moderate (AIS A, B, or C) SCI who were not diagnosed with a sleep disorder prior to the injury
Must not have
Neuromuscular diseases
Concomitant diseases of the central nervous system
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in depression, anxiety & stress scales- 21 from baseline to after 4-month period of cpap therapy
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if CPAP therapy can help improve mental health, thinking, and behavior problems caused by moderate to severe sleep-related breathing disorders in people with spinal cord injury.

Who is the study for?
This trial is for English-speaking adults over 18 with moderate-to-severe sleep-related breathing disorders due to traumatic spinal cord injury between C5 and T10. Participants must be at least 2 months post-injury, not diagnosed with a sleep disorder before the injury, and show symptoms of SRBDs. Excluded are those with chronic fatigue, non-traumatic SCI, kidney failure, certain diseases like hypothyroidism or epilepsy, severe anemia, substance misuse or preinjury chronic pain.
What is being tested?
The study tests if CPAP therapy can help improve mental health, thinking skills and behavior in people who have trouble sleeping because of their spinal cord injury. It focuses on those who haven't been treated for sleep problems before their injury.
What are the potential side effects?
CPAP therapy may cause discomfort such as nasal congestion or dryness, mask discomfort or air leaks around the mask. Some might feel claustrophobic or experience chest muscle discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 or older and speak English.
Select...
I have a spinal cord injury between C5 and T10 without a pre-existing sleep disorder.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a neuromuscular disease.
Select...
I have a brain or spinal cord disease.
Select...
I have epilepsy.
Select...
I have kidney failure.
Select...
I have been diagnosed with chronic fatigue syndrome.
Select...
I have a spinal condition that could get worse.
Select...
I currently have an infection.
Select...
I have been diagnosed with primary hypersomnia.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in depression, anxiety & stress scales- 21 from baseline to after 4-month period of cpap therapy
This trial's timeline: 3 weeks for screening, Varies for treatment, and change in depression, anxiety & stress scales- 21 from baseline to after 4-month period of cpap therapy for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Fatigue Severity Scale
Secondary study objectives
Depression, Anxiety & Stress Scales- 21
Epworth Sleepiness Score
Medical Outcomes Study Sleep Scale
+1 more
Other study objectives
Face-to-face, 1-hour interview for qualitative analysis

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: CPAP-therapy armExperimental Treatment1 Intervention
This single-arm clinical trial will examine the effects of 4-month period CPAP therapy in individuals living with SCI. The CPAP will be adjusted according to the results of the auto-titrating CPAP testing for each participant.

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,531 Previous Clinical Trials
504,298 Total Patients Enrolled
The Craig H. Neilsen FoundationOTHER
60 Previous Clinical Trials
3,024 Total Patients Enrolled
Julio Furlan, MDPrincipal InvestigatorToronto Rehabilitation Institute
1 Previous Clinical Trials
60 Total Patients Enrolled
~3 spots leftby Aug 2025